Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LOEWS CORPL · Entity 3231 | DIRECTOR EMERITUS | June 30, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LOEWS CORP
Report date June 30, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,165 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 102 · Balance 22,165 F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CANTEL MEDICAL CORP
Report date June 02, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-02 transaction · row 1
1 source rowRow 1 · 2021-06-02 · Disposition to issuer · Disposed 2,865,637 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy wife | 0 |
Reported balance
After 2021-06-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-02 · Disposition to issuer · Disposed 374,112 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectBy custodial accounts for benefit of grandchildren | 0 |
Reported balance
After 2021-06-02 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-06-02 · Disposition to issuer · Disposed 185,928 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
| Common Stock, par value $.10 per shareSEC Table I · non-derivative | IndirectShares held by Dico Group, Inc. | 0 |
Reported balance
After 2021-06-02 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-06-02 · Disposition to issuer · Disposed 29,430 · Balance 0 F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration"). F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents (i) a portion of shares that, at the effective time of the First Merger (as defined in the Agreement and Plan of Merger, as amended and restated on March 1, 2021 (the "Merger Agreement"), by and among Cantel Medical Corp., a Delaware corporation (the "Company"), STERIS plc, an Irish public limited company ("STERIS"), Solar New US Holding Co, LLC and Crystal Merger Sub 1, LLC) (the "Effective Time"), were converted into the right to receive (i) 0.33787 ordinary shares, par value $0.001 per share, of STERIS (the "Stock Consideration"), and (ii) $16.93 in cash (the "Cash Consideration" and, together with the Stock Consideration, the "Merger Consideration").
F2: Based on the closing price of ordinary shares of STERIS on June 1, 2021, the last trading day before the Effective Time, the value of the Stock Consideration payable per share of common stock, par value $.10 per share, of the Company ("Company Common Stock") was $63.66, and the value of the Merger Consideration payable per share of Company Common Stock pursuant to the Merger Agreement was $80.59 and (ii) a portion of shares that, at the Effective Time, were converted into STERIS equity awards based on an equity award exchange ratio that is intended to preserve the value of the award immediately before and after the conversion.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 12:50 UTC | LOEWS CORP L · Entity 3231 | GrantCommon Stock | 102 | $0.00 | $0.00 |
DisclosureSEC source: 0000905400-26-000007 · wk-form4_1782910217.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · DIRECTOR EMERITUS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,165 F1 · acquired: Represents quarterly grant of common stock in respect of director compensation (prorated for service through the date of his retirement as a director) under the Loews Corporation 2025 Incentive Compensation Plan. Read SEC document |
| March 31, 2026 Filed Mar 31, 2026 20:23 UTC | LOEWS CORP L · Entity 3231 | GrantCommon Stock | 235 | $0.00 | $0.00 |
DisclosureSEC source: 0000905400-26-000004 · wk-form4_1774988601.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,063 F1 · acquired: Represents quarterly grant of common stock in respect of director compensation under the Loews Corporation 2025 Incentive Compensation Plan. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:20 UTC | LOEWS CORP L · Entity 3231 | GrantCommon Stock | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0000905400-26-000002 · wk-form4_1767648017.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,828 F1 · acquired: Represents quarterly grant of common stock in respect of director compensation under the Loews Corporation 2025 Incentive Compensation Plan. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:31 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $38.67 | $0.00 |
DisclosureSEC source: 0000905400-25-000011 · wk-form4_1764711094.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2025-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:31 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,442 | $107.93 | $155,635.06 |
DisclosureSEC source: 0000905400-25-000011 · wk-form4_1764711094.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,594 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $107.92 and $107.99. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:31 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 808 | $107.87 | $87,158.96 |
DisclosureSEC source: 0000905400-25-000011 · wk-form4_1764711094.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,036 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:31 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $38.67 | $87,007.50 |
DisclosureSEC source: 0000905400-25-000011 · wk-form4_1764711094.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| September 30, 2025 Filed Sep 30, 2025 20:19 UTC | LOEWS CORP L · Entity 3231 | GrantCommon Stock | 251 | $0.00 | $0.00 |
DisclosureSEC source: 0000905400-25-000009 · wk-form4_1759263544.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,594 F1 · acquired: Represents quarterly grant of common stock in respect of director compensation under the Loews Corporation 2025 Incentive Compensation Plan. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:18 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $35.52 | $0.00 |
DisclosureSEC source: 0000905400-25-000007 · wk-form4_1756930708.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2025-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:18 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,422 | $96.76 | $137,592.72 |
DisclosureSEC source: 0000905400-25-000007 · wk-form4_1756930708.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,343 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:18 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 828 | $96.69 | $80,059.32 |
DisclosureSEC source: 0000905400-25-000007 · wk-form4_1756930708.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,765 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 20:18 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $35.52 | $79,920.00 |
DisclosureSEC source: 0000905400-25-000007 · wk-form4_1756930708.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 20:18 UTC | LOEWS CORP L · Entity 3231 | GrantCommon Stock | 149 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-25-000151 · wk-form4_1751401112.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,343 F1 · acquired: Represents quarterly grant of common stock in respect of director compensation under the Loews Corporation 2025 Incentive Compensation Plan. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $38.46 | $0.00 |
DisclosureSEC source: 0000060086-25-000136 · wk-form4_1748981934.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:19 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,274 | $88.37 | $112,583.38 |
DisclosureSEC source: 0000060086-25-000136 · wk-form4_1748981934.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,194 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:19 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 976 | $88.82 | $86,688.32 |
DisclosureSEC source: 0000060086-25-000136 · wk-form4_1748981934.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,468 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 20:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $38.46 | $86,535.00 |
DisclosureSEC source: 0000060086-25-000136 · wk-form4_1748981934.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| May 14, 2025 Filed May 14, 2025 20:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-25-000117 · wk-form4_1747253815.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2024, the Reporting Person was granted 1,288 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F3 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 14, 2024, the Reporting Person was granted 1,288 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 14, 2025 Filed May 14, 2025 20:17 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-25-000117 · wk-form4_1747253815.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $40.61 | $0.00 |
DisclosureSEC source: 0000060086-25-000070 · wk-form4_1741123167.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2025-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:19 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,197 | $86.73 | $103,815.81 |
DisclosureSEC source: 0000060086-25-000070 · wk-form4_1741123167.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,906 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:19 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,053 | $86.89 | $91,495.17 |
DisclosureSEC source: 0000060086-25-000070 · wk-form4_1741123167.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,103 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $40.61 | $91,372.50 |
DisclosureSEC source: 0000060086-25-000070 · wk-form4_1741123167.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $42.52 | $0.00 |
DisclosureSEC source: 0000060086-24-000213 · wk-form4_1733260807.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F2 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:20 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,146 | $86.83 | $99,507.18 |
DisclosureSEC source: 0000060086-24-000213 · wk-form4_1733260807.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,906 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:20 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,104 | $86.80 | $95,827.20 |
DisclosureSEC source: 0000060086-24-000213 · wk-form4_1733260807.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,052 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $42.52 | $95,670.00 |
DisclosureSEC source: 0000060086-24-000213 · wk-form4_1733260807.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $41.98 | $0.00 |
DisclosureSEC source: 0000060086-24-000172 · wk-form4_1725481226.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2024-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 1,088 | $81.37 | $88,530.56 |
DisclosureSEC source: 0000060086-24-000172 · wk-form4_1725481226.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,906 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $81.36 and $81.37. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,162 | $81.42 | $94,610.04 |
DisclosureSEC source: 0000060086-24-000172 · wk-form4_1725481226.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,994 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $41.98 | $94,455.00 |
DisclosureSEC source: 0000060086-24-000172 · wk-form4_1725481226.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $43.83 | $0.00 |
DisclosureSEC source: 0000060086-24-000137 · wk-form4_1717532410.xml · derivative · entry 5 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2024-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 950 | $75.78 | $71,991.00 |
DisclosureSEC source: 0000060086-24-000137 · wk-form4_1717532410.xml · nonDerivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,906 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $75.50 and $75.94. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 13 | $76.59 | $995.67 |
DisclosureSEC source: 0000060086-24-000137 · wk-form4_1717532410.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,856 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,287 | $76.59 | $98,571.33 |
DisclosureSEC source: 0000060086-24-000137 · wk-form4_1717532410.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,869 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:20 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $43.83 | $98,617.50 |
DisclosureSEC source: 0000060086-24-000137 · wk-form4_1717532410.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| May 14, 2024 Filed May 14, 2024 20:27 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 1,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-24-000116 · wk-form4_1715718411.xml · derivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,288 Underlying: Common Stock · 1,288 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (each, an "RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: These RSUs vest on May 14, 2025. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F2 · derivative.expiration_date: These RSUs vest on May 14, 2025. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 09, 2024 Filed May 9, 2024 12:37 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-24-000095 · wk-form4_1715258226.xml · derivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2023, the Reporting Person was granted 1,706 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. F3 · derivative.expiration_date: As previously reported on Table II of a Form 4 filed in connection therewith, on May 9, 2023, the Reporting Person was granted 1,706 RSUs, which vested on the first anniversary of the grant date. The common stock into which such vested RSUs converted is reported on Table I of this Form 4. Read SEC document |
| May 09, 2024 Filed May 9, 2024 12:37 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000060086-24-000095 · wk-form4_1715258226.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · acquired: Represents the conversion into common stock upon vesting of previously awarded restricted stock units ("RSUs"). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:07 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0000060086-24-000071 · wk-form4_1709597233.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2024-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:07 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 951 | $75.02 | $71,344.02 |
DisclosureSEC source: 0000060086-24-000071 · wk-form4_1709597233.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,200 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $75.01 and $75.07. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:07 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,299 | $75.07 | $97,515.93 |
DisclosureSEC source: 0000060086-24-000071 · wk-form4_1709597233.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,151 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 00:07 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $43.37 | $97,582.50 |
DisclosureSEC source: 0000060086-24-000071 · wk-form4_1709597233.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 22, 2023. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $47.84 | $0.00 |
DisclosureSEC source: 0000060086-23-000201 · wk-form4_1701724769.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2023-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:19 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 715 | $70.17 | $50,171.55 |
DisclosureSEC source: 0000060086-23-000201 · wk-form4_1701724769.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,200 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $69.94 and $70.52. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:19 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,535 | $70.08 | $107,572.80 |
DisclosureSEC source: 0000060086-23-000201 · wk-form4_1701724769.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,915 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:19 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,250 | $47.84 | $107,640.00 |
DisclosureSEC source: 0000060086-23-000201 · wk-form4_1701724769.xml · nonDerivative · entry 1 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:08 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionStock Appreciation Right · Derivative | 2,250 | $0.00 Strike: $46.99 | $0.00 |
DisclosureSEC source: 0000060086-23-000162 · wk-form4_1693944504.xml · derivative · entry 4 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,250 shares Expires 2023-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. F3 · price: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:08 UTC | LOEWS CORP L · Entity 3231 | SaleCommon Stock | 561 | $62.56 | $35,096.16 |
DisclosureSEC source: 0000060086-23-000162 · wk-form4_1693944504.xml · nonDerivative · entry 3 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,200 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. F2 · price: Represents the weighted average price of multiple transactions with a range of prices between $62.46 and $62.67. The Reporting Person, upon request by the Commission Staff, the Issuer or a security holder of the Issuer, undertakes to provide further information regarding the number of securities at each separate price sold. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:08 UTC | LOEWS CORP L · Entity 3231 | Disposition to issuerCommon Stock | 1,689 | $62.58 | $105,697.62 |
DisclosureSEC source: 0000060086-23-000162 · wk-form4_1693944504.xml · nonDerivative · entry 2 DIKER CHARLES M · CIK 0000905400 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,761 F1 · kind: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.